AMICUS THERAPEUTICS, INC. Retained Earnings
AMICUS THERAPEUTICS, INC. had Retained Earnings of -$2.77 billion as of 2025-12-31, per its 10-K filed 2026-02-20.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-02-20
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$2.77B.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$2.77B.
- 2025-06-30: Retained Earnings (Accumulated Deficit) -$2.79B.
- 2025-03-31: Retained Earnings (Accumulated Deficit) -$2.76B.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2025-12-31 | -$2.77B 10-K · filed 2026-02-20 | |
| 2025-09-30 | -$2.77B 10-Q · filed 2025-11-04 | |
| 2025-06-30 | -$2.79B 10-Q · filed 2025-07-31 | |
| 2025-03-31 | -$2.76B 10-Q · filed 2025-05-01 | |
| 2024-12-31 | -$2.74B 10-K · filed 2026-02-20 | |
| 2024-09-30 | -$2.75B 10-Q · filed 2024-11-06 | |
| 2024-06-30 | -$2.75B 10-Q · filed 2024-08-08 | |
| 2024-03-31 | -$2.73B 10-Q · filed 2024-05-09 | |
| 2023-12-31 | -$2.68B 10-K · filed 2025-02-19 | |
| 2023-09-30 | -$2.65B 10-Q · filed 2023-11-08 | |
| 2023-06-30 | -$2.63B 10-Q · filed 2023-08-08 | |
| 2023-03-31 | -$2.59B 10-Q · filed 2023-05-10 | |
| 2022-12-31 | -$2.53B 10-K · filed 2024-02-28 | |
| 2022-09-30 | -$2.48B 10-Q · filed 2022-11-07 | |
| 2022-06-30 | -$2.44B 10-Q · filed 2022-08-04 | |
| 2022-03-31 | -$2.38B 10-Q · filed 2022-05-10 | |
| 2021-12-31 | -$2.30B 10-K · filed 2023-03-01 | |
| 2021-09-30 | -$2.21B 10-Q · filed 2021-11-09 | |
| 2021-06-30 | -$2.16B 10-Q · filed 2021-08-05 | |
| 2021-03-31 | -$2.11B 10-Q · filed 2021-05-10 | |
| 2020-12-31 | -$2.05B 10-K · filed 2022-02-24 | |
| 2020-09-30 | -$1.97B 10-Q · filed 2020-11-05 | |
| 2020-06-30 | -$1.91B 10-Q · filed 2020-08-10 | |
| 2020-03-31 | -$1.86B 10-Q · filed 2020-05-07 | |
| 2019-12-31 | -$1.77B 10-K · filed 2021-03-01 | |
| 2019-09-30 | -$1.68B 10-Q · filed 2019-11-12 | |
| 2019-06-30 | -$1.62B 10-Q · filed 2019-08-08 | |
| 2019-03-31 | -$1.53B 10-Q · filed 2019-05-09 | |
| 2018-12-31 | -$1.41B 10-K · filed 2020-03-02 | |
| 2018-09-30 | -$1.33B 10-Q · filed 2018-11-05 | |
| 2018-06-30 | -$1.17B 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $383.00K 10-Q · filed 2018-08-07 | -$1.11B 10-Q · filed 2018-05-09 |
| 2017-12-31 | -$1.06B 10-K · filed 2019-02-28 | |
| 2017-09-30 | -$994.40M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | -$882.74M 10-Q · filed 2017-08-07 | |
| 2017-03-31 | -$834.60M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | -$779.61M 10-K · filed 2018-03-01 | |
| 2016-09-30 | -$720.96M 10-Q · filed 2016-11-07 | |
| 2016-06-30 | -$674.31M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | -$623.26M 10-Q · filed 2016-05-03 | |
| 2015-12-31 | -$579.57M 10-K/A · filed 2017-03-03 | |
| 2015-09-30 | -$536.67M 10-Q · filed 2015-11-04 | |
| 2015-06-30 | -$498.87M 10-Q · filed 2015-08-05 | |
| 2015-03-31 | -$471.74M 10-Q · filed 2015-05-05 | |
| 2014-12-31 | -$447.45M 10-K · filed 2016-02-29 | |
| 2014-09-30 | -$426.23M 10-Q · filed 2014-11-06 | |
| 2014-06-30 | -$409.08M 10-Q · filed 2014-08-07 | |
| 2014-03-31 | -$394.46M 10-Q · filed 2014-05-05 | |
| 2013-12-31 | -$378.52M 10-K · filed 2015-03-03 | |
| 2013-09-30 | -$366.29M 10-Q · filed 2013-11-12 | |
| 2013-06-30 | -$351.70M 10-Q · filed 2013-08-07 | |
| 2013-03-31 | -$336.35M 10-Q · filed 2013-05-09 | |
| 2012-12-31 | -$318.89M 10-K · filed 2014-03-03 | |
| 2012-09-30 | -$308.87M 10-Q · filed 2012-11-06 | |
| 2012-06-30 | -$292.58M 10-Q · filed 2012-08-08 | |
| 2012-03-31 | -$283.24M 10-Q · filed 2012-05-11 | |
| 2011-12-31 | -$270.10M 10-K · filed 2013-03-13 | |
| 2011-09-30 | -$261.44M 10-Q · filed 2011-11-02 | |
| 2011-06-30 | -$251.68M 10-Q · filed 2011-08-11 | |
| 2010-12-31 | -$225.69M 10-K · filed 2012-02-28 |